GLP-1s for Rheumatoid Arthritis For people with rheumatoid arthritis (RA) who are also overweight or who have obesity, GLP-1s may offer additional benefits
Case Info GLP-1 Medications and NAION Vision Loss Lawsuit GLP-1 receptor agonists, widely prescribed to treat Type 2 diabetes and weight loss, have been linked to a higher risk of NAION
FDAs concerns with unapproved GLP-1 drugs used for weight loss, United States Food and Drug Administration (2024) FDA approves first oral GLP-1 treatment for Type 2 diabetes, United States Food and Drug Administration (2019) Semaglutide for Type 2 diabetes, CADTH Health Technology Review (2023) Anti-inflammatory benefits of semaglutide: State of the art, Journal of Clinical & Translational Endocrinology (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
While many patients experience benefits from taking GLP-1s, there are some fairly significant side effects associated with these medications
Creates a more natural-looking tan: Helps reduce patchiness and uneven tones, leading to smoother, more uniform skin coloration